Protein Leakage Assay
Protein Leakage Assay - Related Videos
02:58
Fluorescence Leakage Assay to Study Cell-Penetrating Peptide Interaction with Membrane
0 Views •
2025
This video discusses the fluorescence leakage assay to study the interactions of cell-penetrating peptides with cell membranes using cell membrane mimics — large unilamellar vesicles, or LUVs, encapsulated with a fluorescent dye and a quencher.
07:33
Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide
0 Views •
Cited by 4 •
2020
The fluorescence leakage assay is a simple method that enables the investigation of peptide/membrane interactions in order to understand their involvement in several biological processes and especially the ability of cell-penetrating peptides to disturb phospholipids bilayers during a direct cellular translocation process.
06:35
Linearization of the Bradford Protein Assay
0 Views •
Cited by 292 •
2010
The accuracy and sensitivity of protein determination by the rapid and convenient Bradford assay is compromised by intrinsic nonlinearity. We show a simple linearization procedure that greatly increases the accuracy, improves the sensitivity of the assay about 10-fold, and significantly reduces interference by detergents.
10:56
Assays for the Degradation of Misfolded Proteins in Cells
0 Views •
Cited by 5 •
2016
This report describes protocols for measuring degradation rates of misfolded proteins by either western blot or fluorescence-based assays. The methods can be applied to analysis of other misfolded proteins and for high throughput screening.
04:05
Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
0 Views •
2025
Here, we present a protocol for endoscopic vacuum therapy (EVT) in the management of anastomotic leaks following total gastrectomy with esophagojejunostomy.
FAQs
An increase in protein measured in the surrounding fluid suggests that more cellular or compartmental material has crossed a normally retaining membrane. The result therefore serves as a quantitative indicator of structural damage, rather than merely showing that a biological system was exposed to a treatment. In medical studies, this helps connect an intervention or disease process with loss of membrane integrity.
A measured protein concentration has meaning only relative to an appropriate reference condition. Controls provide the baseline against which leakage associated with injury, disease, toxins, or treatment can be judged. Comparing samples in this way helps determine whether an observed increase reflects the tested condition rather than differences already present in the biological material.
No. It reports the extent of protein release and therefore provides evidence of compromised structural integrity, but leakage alone does not identify whether injury, disease, a toxin, or a treatment produced the change. Investigators interpret the measurement alongside the experimental condition and controls. This makes the assay useful for characterizing damage without treating one readout as a complete mechanism.
The surrounding fluid collected from cells, tissue, or a biological compartment is the analytical sample because it contains protein released after membrane compromise. That sample is then examined with a protein-detection method, and its measurement is compared with appropriate controls. The workflow converts an otherwise qualitative sign of leakage into a quantitative indicator of structural damage.
A study first evaluates cells, tissue, or a biological compartment under the condition of interest, such as injury, disease, toxin exposure, or treatment. Researchers then collect the surrounding fluid, apply a protein-detection method, and compare the result with controls. The resulting measurement supports assessment of membrane integrity and the extent of associated cellular damage.
It is useful when investigators need to determine whether a treatment damages membranes or affects structural integrity. Measurements can support cytotoxicity assessment, examination of drug effects, and evaluation of a candidate intervention’s safety or therapeutic potential. Because the assay provides a quantitative damage-related readout, treatment groups can be compared with controls to characterize beneficial or harmful effects.
Protein release provides a measurable link between membrane disruption and the broader biological condition under study. In tissue injury or disease research, the value lies in quantifying structural damage rather than relying only on descriptive observations. This can help investigators characterize disease mechanisms and assess whether an intervention changes the membrane-disrupting process.